Investing in Pulmonary Hypertension.
Download our latest infographic to find out why you should be investing in pulmonary hypertension...
By Victoria Hudson, Senior Analyst
27 July 2015
I am the senior analyst for Datamonitor Healthcare’s cardiovascular and metabolic team, and cover everything from acut...
Read full bio
If you need to fill the white space in your portfolio than this infographic could help you find a way. Pulmonary hypertension (PH) is an indication that needs extensive research, and more than anything needs a sustainable cure.
Our infographic takes you through why this investment is needed in this area and the competition you may come up against.
What’s included in our infographic?
- Key opinion leader insight into the main unmet needs within this indication
- The impact of off-label usage on drug sales
- An overview of therapies currently in development for PH